1. Catalogs
  2. Abaxis Europe
  3. Financial Impact

Financial Impact

Financial Impact

Financial Impact

Product catalog summary
Overview: The document outlines the benefits and financial implications of using the Piccolo Xpress™ point-of-care diagnostic device by Abaxis, Inc. It emphasizes the device's ability to provide lab-accurate chemistry results in 12 minutes, enhancing patient care and practice efficiency.
Key Features:
  • Single Visit Diagnosis and Treatment: Enables lab-accurate diagnostics and treatment within a single patient visit, improving practice throughput and revenue.
  • Improved Patient Care: Real-time lab results allow for better monitoring of medication efficacy and more meaningful consultations, enhancing patient compliance and satisfaction.
  • Medicare Incentives: The device supports new Medicare programs like the Annual Wellness Visit (AWV) and the Primary Care Incentive Payment (PCIP), allowing for on-site treatment of abnormalities and increased visit complexity.
Financial Impact:
  • Reimbursement Details: The document provides a detailed table of Medicare national average reimbursements for various diagnostic panels, highlighting the financial benefits of using the Piccolo Xpress™.
  • Bundling Note: When certain panels are run together, CMS bundles them for a combined reimbursement rate, which is specified in the document.
Conclusion: The Piccolo Xpress™ offers a fast, easy, and accurate solution for on-site chemistry testing, improving practice revenues and patient care delivery. It is crucial for practices to consider all factors of practice improvement when determining the return on investment.
See more

Catalog excerpts

Financial Impact-1

FAST, EASY, ACCURATE ON-SITE CHEMISTRY TESTING FINANCIAL IMPACT OF POINT-OF-CARE DIAGNOSTICS IMPROVE THE HEALTH OF YOUR PRACTICE WITH REAL TIME CHEMISTRY. The easiest way to improve practice revenues and care delivery is through point-of-care diagnostics. With onsite chemistry analysis, the majority of patients can be diagnosed and treated in a single visit, thereby increasing throughput and revenue. With the Piccolo, you can: ________________________________________________________________ • Increase practice revenues without increasing complexity • Maximize patient throughput and practice capacity • Diagnose, monitor and treat within a single patient visit • Take full advantage of healthcare reform incentives • Improve patient care and treatment compliance DIAGNOSE AND TREAT IN A SINGLE VISIT Accomplish more during each patient visit without adding time or burden. • Lab-accurate, CLIA waived chemistry - in just 12 minutes • A broad menu of general chemistry diagnostic tests • Simple 3-step operation that anyone can master O INCREASE PRACTICE THROUGHPUT & REVENUE Real-time lab results allow you to diagnose, treat with greater efficacy, resulting in: • Higher value, single visit patient evaluation & management • Dramatic increases in throughput and revenues • The ability to address a majority of abnormals on-site ____________________________________________________________________________________________ O IMPROVE PATIENT CARE AND COMPLIANCE Armed with accurate information during the patient visit, physicians can: • Monitor medication efficacy and impact in real-time • Conduct more meaningful consultations based on real-time lab results • Improve patient compliance and increase satisfaction ____________________________________________________________________________________________ O TAKE ADVANTAGE OF NEW MEDICARE INCENTIVES CMS has added two important programs for PCPs - the Annual Wellness Visit (AWV) and the 10% Primary Care Incentive Payment (PCIP). With the Piccolo, you can: • Perform labs during the AWV and address abnormals during the initial visit • Add an appropriate E&M code in addition to the AWV if abnormals are treated on-site • Provide lab-accurate diagnostics for your medicare patients - in one visit • Increase the value of the PCIP through higher complexity visits 3240 Whipple Rd., Union City, CA 94587 | 800.822.2947 | www.piccoloxpress.com ©2013 Abaxis, Inc., Piccolo Xpress™ is a trademark of Abaxis, Inc. 888-3229 Rev.C

 Open the catalog to page 1
Financial Impact-2

PICCOLO XPRESS PANEL REIMBURSEMENT - MEDICARE NATIONAL AVERAGE 2013 CLIA Waived Tests Comprehensive Metabolic Panel Basic Metabolic Panel Lipid Panel CHOL, HDL, CHOL/HDL*, LDL*, nHDLc*, TRIG, VLDL* Lipid Panel Plus CHOL, HDL, CHOL/HDL*, LDL*, nHDLc*, TRIG, VLDL*, GLU, ALT, AST Liver Panel Plus Electrolyte Panel Renal Function Panel Kidney Check Hepatic Function Panel Basic Metabolic Panel Plus BioChemistry Panel Plus Important note: When a CMP (80053QW) is run with a Lipid panel (80061QW) on the same patient in the same day, CMS will bundle the two tests as an ATP 16 plus HDL (83718QW). For 2013,...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.